MSB vs TECH
Mesabi Trust (MSB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Mesabi Trust (MSB) is a steel company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MSB revenue for 2025-01-31 was $98.6M. Net income was $93.3M. MSB currently screens at market cap $324.3M and trailing P/E 28.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MSB currently screens at market cap $324.3M and trailing P/E 28.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MSB and TECH stock pages for the full models.
Not investment advice.